p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer.
Liu J, He D, Cheng L, Huang C, Zhang Y, Rao X, Kong Y, Li C, Zhang Z, Liu J, Jones K, Napier D, Lee EY, Wang C, Liu X.
Liu J, et al. Among authors: wang c.
Oncogene. 2020 May;39(19):3939-3951. doi: 10.1038/s41388-020-1270-z. Epub 2020 Mar 23.
Oncogene. 2020.
PMID: 32203167
Free PMC article.